Bookvolume editors, Lluís Puig, Wayne Gulliver.
Contents:
Adverse reactions to biologics in psoriasis / Lockwood, S.J., Prens, L.M.; Kimball, A.B.
Clinical trial and registry data / Gooderham, M., Papp, K.
Immunosuppression/infections across indications / Al-Khalili, A., Dutz, J.P.
The immunogenicity of biologic therapies / Garcias, S., Demengeot, J.
Paradoxical reaction S : anti-tumor necrosis factor alpha agents, Ustekinumab, Secukinumab, Ixekizumab, and others / Puig, L.
Bullous diseases / Corbaux, C., Joly, P.
Adverse reactions of antibody-therapy for primary cutaneous lymphomas : Rituximab, Brentuximab vedotin, Alemtuzumab, and Mogamulizumab / Saulite, I., Guenova, E., Hoetzenecker, W.
Adverse reactions to biologics : melanoma (Ipilimumab, Nivolumab, Pembrolizumab) / Hwang, S.J.E., Fernández-Peñas, P.
Skin manifestations of targeted antineoplastic therapy / Sanmartín, O.